Isabelle Passagne
- Materials Chemistry top 10%
- Molecular Biology
- Health, Toxicology and Mutagenesis top 5%
- Biomedical Engineering
- Biomaterials
- Co-authors
- B. L’AzouIgor PujaltéCéline Ohayon‐CourtèsBrigitte BrouillaudMona TréguerÉtienne DurandPierre CuqAlexandre Evrard
- Topics
- Nanoparticles: synthesis and applications (5 papers)Heavy Metal Exposure and Toxicity (5 papers)Cancer therapeutics and mechanisms (2 papers)
- Journals
- Analytical ChemistryBritish Journal of CancerJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- FranceNew ZealandUnited States
In The Last Decade
Isabelle Passagne
15 papers receiving 752 citations
Peers
Comparison fields: 5 of 102
- Materials Chemistry 385
- Molecular Biology 205
- Health, Toxicology and Mutagenesis 153
- Biomedical Engineering 134
- Biomaterials 89
Countries citing papers authored by Isabelle Passagne
This map shows the geographic impact of Isabelle Passagne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Passagne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Passagne more than expected).
Fields of papers citing papers by Isabelle Passagne
This network shows the impact of papers produced by Isabelle Passagne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Passagne. The network helps show where Isabelle Passagne may publish in the future.
Co-authorship network of co-authors of Isabelle Passagne
This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Passagne. A scholar is included among the top collaborators of Isabelle Passagne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Passagne. Isabelle Passagne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 23 | |
| 3 | 40 | |
| 4 | 134 | |
| 5 | 315 | |
| 6 | 1 | |
| 7 | 25 | |
| 8 | Cytotoxic and apoptotic effects of bortezomib and gefitinib compared to alkylating agents on human glioblastoma cells. | 15 |
| 9 | 6 | |
| 10 | 1 | |
| 11 | 68 | |
| 12 | 21 | |
| 13 | 61 | |
| 14 | 20 | |
| 15 | 26 |
About Isabelle Passagne
Isabelle Passagne is a scholar working on Health, Toxicology and Mutagenesis, Biophysics and Electrochemistry, having authored 15 papers that have together received 762 indexed citations. Recurring topics across this work include Nanoparticles: synthesis and applications (5 papers), Heavy Metal Exposure and Toxicity (5 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (153 citations), Materials Chemistry (385 citations) and Biomaterials (89 citations). Isabelle Passagne has collaborated with scholars based in France, New Zealand and United States. Frequent co-authors include B. L’Azou, Igor Pujalté, Céline Ohayon‐Courtès, Brigitte Brouillaud, Mona Tréguer, Étienne Durand, Pierre Cuq, Alexandre Evrard, Philippe Depeille and Laurence Vian. Their work appears in journals such as Analytical Chemistry, British Journal of Cancer and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.